Podcasts

An expert presents the results of a phase 2 study on the impact of rituximab on myasthenia gravis.

An expert describes the efficacy of fenfluramine in decreasing seizure frequency associated with this rare syndrome.

A unique case of chronic, low level carbon monoxide poisoning in a car mechanic that resulted in Parkinsonian symptoms.

What does epigenetics have to do with risk for Alzheimer disease? Are our epigenetics immutable? What are the therapeutic implications? Those questions answered in this podcast.

What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?

An expert discusses the latest guidelines to reduce brain injury in adults who are comatose after cardiac resuscitation.

Key details about an option for the treatment of drug-resistant epilepsy in patients who are not surgical candidates.

Alzheimer disease is not an equal opportunity employer. Insights about early life stressors and economic disadvantage.

What do the new AAN guidelines on SUDEP offer? Here’s a quick overview of the key facts.

The largest study of its kind shows that 8 in 1000 people have epilepsy--a distinctly higher incidence than previously thought. Details and implications in this podcast.

In this podcast, Ann Scher, PhD, lead author in a recently published study, gives a succinct overview of the details and briefly discusses what the findings may suggest.

Persons with epilepsy have a higher prevalence of comorbid conditions-psychiatric disorders in particular-than the general population.